Literature DB >> 26962217

Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere.

Helen M Lazear1, Michael S Diamond2.   

Abstract

Zika virus (ZIKV) had remained a relatively obscure flavivirus until a recent series of outbreaks accompanied by unexpectedly severe clinical complications brought this virus into the spotlight as causing an infection of global public health concern. In this review, we discuss the history and epidemiology of ZIKV infection, recent outbreaks in Oceania and the emergence of ZIKV in the Western Hemisphere, newly ascribed complications of ZIKV infection, including Guillain-Barré syndrome and microcephaly, potential interactions between ZIKV and dengue virus, and the prospects for the development of antiviral agents and vaccines.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26962217      PMCID： PMC4859708          DOI： 10.1128/JVI.00252-16

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  138 in total

1.  Zika virus. I. Isolations and serological specificity.

Authors:  G W A DICK; S F KITCHEN; A J HADDOW
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-09       Impact factor: 2.184

Review 2.  Zika virus: a previously slow pandemic spreads rapidly through the Americas.

Authors:  Derek Gatherer; Alain Kohl
Journal:  J Gen Virol       Date:  2015-12-18       Impact factor: 3.891

3.  Microcephaly in Brazil: how to interpret reported numbers?

Authors:  Cesar Gomes Victora; Lavinia Schuler-Faccini; Alicia Matijasevich; Erlane Ribeiro; André Pessoa; Fernando Celso Barros
Journal:  Lancet       Date:  2016-02-07       Impact factor: 79.321

4.  Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses.

Authors:  Pornapat Surasombatpattana; Rodolphe Hamel; Sirilaksana Patramool; Natthanej Luplertlop; Frédéric Thomas; Philippe Desprès; Laurence Briant; Hans Yssel; Dorothée Missé
Journal:  Infect Genet Evol       Date:  2011-06-21       Impact factor: 3.342

5.  Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses.

Authors:  G Kuno; G-J J Chang
Journal:  Arch Virol       Date:  2007-01-03       Impact factor: 2.574

6.  Excretion of West Nile virus in urine during acute infection.

Authors:  Luisa Barzon; Monia Pacenti; Elisa Franchin; Silvana Pagni; Thomas Martello; Margherita Cattai; Riccardo Cusinato; Giorgio Palù
Journal:  J Infect Dis       Date:  2013-07-02       Impact factor: 5.226

7.  Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus.

Authors:  Kazuya Shirato; Hirotsugu Miyoshi; Akiko Goto; Yoshihiko Ako; Tomotaka Ueki; Hiroaki Kariwa; Ikuo Takashima
Journal:  J Gen Virol       Date:  2004-12       Impact factor: 3.891

8.  West Nile virus in 2006 and 2007: the Canadian Blood Services' experience.

Authors:  Sheila F O'Brien; Vito Scalia; Edna Zuber; Gordon Hawes; Edward C Alport; Mindy Goldman; Margaret A Fearon
Journal:  Transfusion       Date:  2009-12-29       Impact factor: 3.157

9.  Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening.

Authors:  Brian Custer; Hany Kamel; Nancy E Kiely; Edward L Murphy; Michael P Busch
Journal:  Transfusion       Date:  2009-02       Impact factor: 3.157

10.  Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.

Authors:  Van-Mai Cao-Lormeau; Alexandre Blake; Sandrine Mons; Stéphane Lastère; Claudine Roche; Jessica Vanhomwegen; Timothée Dub; Laure Baudouin; Anita Teissier; Philippe Larre; Anne-Laure Vial; Christophe Decam; Valérie Choumet; Susan K Halstead; Hugh J Willison; Lucile Musset; Jean-Claude Manuguerra; Philippe Despres; Emmanuel Fournier; Henri-Pierre Mallet; Didier Musso; Arnaud Fontanet; Jean Neil; Frédéric Ghawché
Journal:  Lancet       Date:  2016-03-02       Impact factor: 79.321
View more
  225 in total

1.  Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice.

Authors:  Annie Elong Ngono; Edward A Vizcarra; William W Tang; Nicholas Sheets; Yunichel Joo; Kenneth Kim; Matthew J Gorman; Michael S Diamond; Sujan Shresta
Journal:  Cell Host Microbe       Date:  2017-01-11       Impact factor: 21.023

2.  Characterization of two engineered dimeric Zika virus envelope proteins as immunogens for neutralizing antibody selection and vaccine design.

Authors:  Chunpeng Yang; Fang Zeng; Xinyu Gao; Shaojuan Zhao; Xuan Li; Sheng Liu; Na Li; Chenglin Deng; Bo Zhang; Rui Gong
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

3.  Replication of early and recent Zika virus isolates throughout mouse brain development.

Authors:  Amy B Rosenfeld; David J Doobin; Audrey L Warren; Vincent R Racaniello; Richard B Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-31       Impact factor: 11.205

4.  Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.

Authors:  Justin M Richner; Brett W Jagger; Chao Shan; Camila R Fontes; Kimberly A Dowd; Bin Cao; Sunny Himansu; Elizabeth A Caine; Bruno T D Nunes; Daniele B A Medeiros; Antonio E Muruato; Bryant M Foreman; Huanle Luo; Tian Wang; Alan D Barrett; Scott C Weaver; Pedro F C Vasconcelos; Shannan L Rossi; Giuseppe Ciaramella; Indira U Mysorekar; Theodore C Pierson; Pei-Yong Shi; Michael S Diamond
Journal:  Cell       Date:  2017-07-13       Impact factor: 41.582

5.  A Vesicular Stomatitis Virus-Based Vaccine Carrying Zika Virus Capsid Protein Protects Mice from Viral Infection.

Authors:  Xiaodan Shi; Jingping Hu; Jing Guo; Chuanjian Wu; Sidong Xiong; Chunsheng Dong
Journal:  Virol Sin       Date:  2019-02-28       Impact factor: 4.327

6.  Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus.

Authors:  Ming Yang; Matthew Dent; Huafang Lai; Haiyan Sun; Qiang Chen
Journal:  Vaccine       Date:  2017-06-29       Impact factor: 3.641

7.  Host response: Cross-fit T cells battle Zika virus.

Authors:  Matthew Collins; Aravinda de Silva
Journal:  Nat Microbiol       Date:  2017-05-25       Impact factor: 17.745

8.  Smartphone-Based Mobile Detection Platform for Molecular Diagnostics and Spatiotemporal Disease Mapping.

Authors:  Jinzhao Song; Vikram Pandian; Michael G Mauk; Haim H Bau; Sara Cherry; Laurence C Tisi; Changchun Liu
Journal:  Anal Chem       Date:  2018-03-22       Impact factor: 6.986

Review 9.  Zika virus - reigniting the TORCH.

Authors:  Carolyn B Coyne; Helen M Lazear
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

Review 10.  Zika virus: An emergent neuropathological agent.

Authors:  Martyn K White; Hassen S Wollebo; J David Beckham; Kenneth L Tyler; Kamel Khalili
Journal:  Ann Neurol       Date:  2016-08-10       Impact factor: 10.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.